| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Tyrosine-protein kinase JAK2 [831-1132] |
|---|
| Ligand | BDBM264237 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Enzyme Inhibition Assay |
|---|
| IC50 | 9260±n/a nM |
|---|
| Citation |  Astrand, AB; Grimster, NP; Kawatkar, S; Kettle, JG; Nilsson, MK; Ruston, L; Su, Q; Vasbinder, M; Winter-Holt, JJ; Woessner, RD; Chuaqui, CE; McCabe, J Compounds and methods for inhibiting JAK US Patent US10654835 Publication Date 5/19/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Tyrosine-protein kinase JAK2 [831-1132] |
|---|
| Name: | Tyrosine-protein kinase JAK2 [831-1132] |
|---|
| Synonyms: | JAK2 | JAK2 (aa 831-1132) | JAK2_HUMAN | Tyrosine-protein kinase JAK2 (aa 831-1132) |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 35337.99 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O60674[831-1132] |
|---|
| Residue: | 302 |
|---|
| Sequence: | GFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE
HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH
IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV
KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ
GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM
AG
|
|
|
|---|
| BDBM264237 |
|---|
| n/a |
|---|
| Name | BDBM264237 |
|---|
| Synonyms: | (2R)-N-(3-{2- [(1,3-dimethyl-1H- pyrazol-4-yl)amino] pyrimidin-4-yl}- 1H-indol-7-yl)-2- (4-methylpiperazin- 1-yl)propanamide | US10167276, Example 57 | US10654835, Example 57 | US11247983, Example 57 | US9714236, 57 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C25H31N9O |
|---|
| Mol. Mass. | 473.5733 |
|---|
| SMILES | C[C@@H](N1CCN(C)CC1)C(=O)Nc1cccc2c(c[nH]c12)-c1ccnc(Nc2cn(C)nc2C)n1 |r| |
|---|
| Structure | 
|
|---|
Search and Browse
